Abbott P/B Ratio
Abbott (ABBOTINDIA) P/B ratio is 11.38 (High), book value per share ₹2273.33 vs Healthcare average P/B of -0.35 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see ABBOTINDIA share price screener.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ABBOTINDIA P/B Ratio — Valuation Insights & Book Value Analysis
Abbott price-to-book ratio interpretation, valuation status and historical context — current P/B 11.38 (High). Compare with ABBOTINDIA fair value to assess whether the stock is under or overvalued.
- Stock appears overvalued with PB of 11.38, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 22.6% below historical average
- Trading at premium to sector average PB of -0.35
Abbott P/B Ratio Historical Trend
ABBOTINDIA annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. View ABBOTINDIA 52-week chart for the annual high/low range and current price position.
ABBOTINDIA Historical P/B Ratio — Book Value Per Share & Year-End Price
Abbott annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 11.25 | ₹2273.33 | ₹25585.00 | ₹4,774 | High |
| 2025 | 14.4 | ₹2015.71 | ₹29025.00 | ₹4,233 | High |
| 2024 | 16.88 | ₹1761.43 | ₹29741.00 | ₹3,699 | High |
| 2023 | 15.05 | ₹1518.57 | ₹22851.25 | ₹3,189 | High |
| 2022 | 15.91 | ₹1342.86 | ₹21367.20 | ₹2,820 | High |
ABBOTINDIA vs Healthcare Peers — P/B Ratio Comparison
Abbott P/B 11.38 vs Healthcare average -0.35, median 0.61 — range -18.41–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -3.86 | ₹27 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.57 | ₹49 | Low |